TrialJAMA ophthalmology2017
Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
Susan B Bressler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
77 papers cite itlatest 60 shown
this paperpooled ittrialcites it